chronic kidney diseasehypertensiontype 2 diabetes mellitusT2DMCKD
…h the risk of type 2 diabetes mellitus (T2DM), hypertension and chronic kidney disease (CKD).Design, setting This retrospective cohort study used data…
Browse by entity family
An entity family is a category of extracted information. Choose one to browse its named entities and supporting articles.
Funders
Organisations named as supporting, sponsoring, or funding research.
5,089 articles · 9,137 mentionsInstitutionsUniversities, hospitals, research centres, networks, and public bodies.
11,350 articles · 22,378 mentionsDrugsNamed medicines, compounds, vaccines, and pharmacological agents.
10,506 articles · 58,393 mentionsDiseasesNamed diseases, disorders, syndromes, injuries, and health conditions.
23,712 articles · 125,551 mentionsTreatmentsClinical therapies and care approaches used to manage a condition.
7,227 articles · 16,644 mentionsInterventionsProgrammes, procedures, policies, and other actions being evaluated.
4,132 articles · 9,994 mentionsClinical instrumentsNamed questionnaires, scales, scores, indices, and other clinical outcome assessments.
945 articles · 1,957 mentions29,499matching articles
244,054matching entity mentions
30popular entities listed
0%of mentions human-reviewed
Popular entities in these results
Choose an entity to see the articles in which it was identified.
EMBASE784PUBMED717COVID-19645Cancer605SLE570Diabetes552NHS522WEB OF SCIENCE499Hypertension418SCOPUS417HIV406Systemic Lupus Erythematosus390Heart Failure364Asthma349Stroke336COPD331WHO330Colorectal Cancer327Cardiovascular Disease317Type 2 Diabetes316Chronic Obstructive Pulmonary Disease313Joanna Briggs Institute306MEDLINE306Atrial Fibrillation283Cochrane Library275Breast Cancer271Hepatocellular Carcinoma253SSc251Inflammatory Bowel Disease250Obesity246
Matching articles
29,499 articles · page 94 of 2459aspirinticagrelorNIH Stroke Scalealteplasetenecteplase
…label aspirin for days 2–7. Both groups will receive open-label aspirin (100 mg daily) for days 8–90.Study outcomes The primary efficac…
melanomabreasthaematologic malignancieslungcolorectal cancersgynaecologicBCL-2 inhibitorscheckpoint inhibitorscancer
…ommon in adolescents and young adults (AYAs), including breast, melanoma, lung, gynaecologic, colorectal cancers and haematologic malign…
94.7%
HFpEFNT-proBNPCA125heart failure
…A125 exhibits acceptable diagnostic performance for identifying HFpEF and may complement NT-proBNP in clinical practice.…
cardiovascular diseaserespiratory diseasediabetescancer
…years of follow-up, 38 847 deaths were recorded, with 9901 from cardiovascular disease, 10 719 from cancer, and 3159 from respiratory disease. Total p…
DesmopressinHyponatraemiaosmotic demyelination syndromerenal dysfunction
… avoid complications, including osmotic demyelination syndrome. Desmopressin can be used to prevent rapid fluctuations in sodium. While effe…
COPDchronic obstructive pulmonary diseaseEnvironmental Protection AdministrationNational Taiwan University Hospital Yunlin BranchLAMAsSABAsLABAsinhaled therapytriple therapyLAMA+2 more
…pective study, higher ambient PM 2.5 was associated with higher COPD acute exacerbation (AE) rates, and greater use of triple therap…
lacunar strokecortical strokeIntravenous thrombolysisQatar Stroke Registryischaemic strokert-PArecombinant tissue-type plasminogen activatordiabetes mellitus
…t 90 days for cortical stroke post rt-PA (p<0.001), whereas for lacunar stroke, both high admission NIHSS score (>10) and symptom onset of >3 …
ASCVDsepsiscoronary artery diseasepolyvascular diseaseatherosclerotic cardiovascular diseaseperipheral artery disease
…ents with sepsis.Conclusion Integrated management of sepsis and ASCVD—using targeted interventions such as tailored pharmacotherapy a…
Multiple sclerosisMOGADneuromyelitis optica spectrum disordermyelin oligodendrocyte glycoprotein antibody-associated diseaseMSNMOSD
…Background Multiple sclerosis (MS), neuromyelitis optica spectrum disorder (NMOSD) and myelin…
OzoralizumabHealth Assessment Questionnairerheumatoid arthritismethotrexateLJIRA
… were similar between the groups in the OHZORA trial.Conclusion Ozoralizumab has the potential to improve disease activity and physical dysf…